Eli Lilly and Company (LLY) News Today $759.76 -3.19 (-0.42%) Closing price 03:59 PM EasternExtended Trading$758.72 -1.03 (-0.14%) As of 04:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why Is Eli Lilly and Company Down Today?Toggle Visibility of Why Is Eli Lilly and Company Down Today?Eli Lilly and Company (LLY) shares have fluctuated as investors balance strong clinical data and strategic advances against market headwinds. Robust Phase 3 results in Alzheimer’s and oncology, along with bullish analyst commentary and a competitive edge over a faltering rival, were tempered by profit-taking, a broad market pullback, and lingering questions about weight-loss drug demand. Positive Sentiment: BMO Capital Markets says LLY will benefit from an onshoring boom and highlights a promising Alzheimer’s treatment. Eli Lilly Stock (LLY) Will Benefit from ‘Onshoring Boom,’ Says BMO Capital Markets Positive Sentiment: Phase 3 LTE results for Kisunla (donanemab-azbt) show growing benefit over three years in early symptomatic Alzheimer’s, supporting early intervention. Lilly's Kisunla (donanemab-azbt) showed growing benefit over three years in early symptomatic Alzheimer's disease Positive Sentiment: Citi sees LLY poised for upside following its recent selloff. Eli Lilly (LLY) Poised for Upside After Recent Selloff, Says Citi Positive Sentiment: Rival Novo Nordisk’s 20% plunge on guidance cuts boosts Eli Lilly’s competitive positioning in obesity and diabetes. Novo Nordisk Stock (NVO) Plunges 20% on Guidance Cut and CEO Appointment Positive Sentiment: Lilly’s Jaypirca (pirtobrutinib) met its primary endpoint in a Phase 3 head-to-head trial versus Imbruvica in CLL/SLL. Lilly's Jaypirca (pirtobrutinib) met its primary endpoint in a head-to-head Phase 3 trial versus Imbruvica Positive Sentiment: Reuters reports Jaypirca outperformed AbbVie’s Imbruvica in a head-to-head blood cancer study. Lilly's cancer drug more effective than AbbVie's in head-to-head study Positive Sentiment: Eli Lilly acquires Verve Therapeutics, expanding its gene-editing pipeline. Lilly Acquires Verve Therapeutics Positive Sentiment: Investors expect Lilly to report stronger quarterly results than Novo Nordisk after Novo’s profit warning. Lilly set for strong quarter after Novo profit warning Positive Sentiment: Eli Lilly announces new Phase 3 trial results for Orforglipron, advancing its obesity drug franchise. Eli Lilly and Company (LLY) Announces New Phase 3 Trial Results for Orforglipron Neutral Sentiment: Analysts show mixed views on Eli Lilly alongside peers Centene and HCA Healthcare. Analysts Have Conflicting Sentiments on These Healthcare Companies: Eli Lilly & Co (LLY)... Negative Sentiment: Shares gap down amid broader market pullback. Eli Lilly and Company (NYSE:LLY) Shares Gap Down - What's Next? Negative Sentiment: LLY declined over 5.5%, underperforming the broader market. Eli Lilly (LLY) Declines More Than Market: Some Information for Investors Negative Sentiment: Stock dragged down by concerns over weight-loss drug demand after Novo lowers guidance. Eli Lilly Stock (LLY) Gets Dragged Down After Rival Novo Nordisk Lowers Guidance Negative Sentiment: Marketbeat notes a 4.2% drop as profit-taking intensifies. Eli Lilly and Company (NYSE:LLY) Shares Down 4.2% - Here's What Happened Posted 21m agoAI Generated. May Contain Errors. LLY Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Eli Lilly Stock (LLY) Will Benefit from ‘Onshoring Boom,’ Says BMO Capital Markets4 hours ago | tipranks.comLilly's Kisunla (donanemab-azbt) showed growing benefit over three years in early symptomatic Alzheimer's diseaseJuly 30 at 8:01 AM | prnewswire.comEli Lilly and Company (NYSE:LLY) Shares Acquired by Natixis Advisors LLCJuly 30 at 6:14 AM | marketbeat.comNorth Star Asset Management Inc. Has $13.28 Million Holdings in Eli Lilly and Company (NYSE:LLY)July 30 at 6:14 AM | marketbeat.comGS Investments Inc. Makes New $2.38 Million Investment in Eli Lilly and Company (NYSE:LLY)July 30 at 6:14 AM | marketbeat.comTower Bridge Advisors Sells 868 Shares of Eli Lilly and Company (NYSE:LLY)July 30 at 6:14 AM | marketbeat.comBristol Gate Capital Partners Inc. Buys Shares of 118,275 Eli Lilly and Company (NYSE:LLY)July 30 at 6:13 AM | marketbeat.comModera Wealth Management LLC Sells 1,236 Shares of Eli Lilly and Company (NYSE:LLY)July 30 at 6:13 AM | marketbeat.comEli Lilly and Company (NYSE:LLY) Shares Bought by Baader Bank AktiengesellschaftJuly 30 at 6:13 AM | marketbeat.comEli Lilly and Company (NYSE:LLY) Position Trimmed by Howard Capital Management Inc.July 30 at 6:13 AM | marketbeat.comEli Lilly and Company (NYSE:LLY) is Wellington Shields & Co. LLC's 4th Largest PositionJuly 30 at 6:13 AM | marketbeat.comWoodley Farra Manion Portfolio Management Inc. Cuts Stock Holdings in Eli Lilly and Company (NYSE:LLY)July 30 at 6:13 AM | marketbeat.comEli Lilly and Company (NYSE:LLY) Shares Sold by Mesirow Financial Investment Management Inc.July 30 at 6:13 AM | marketbeat.comArkadios Wealth Advisors Raises Holdings in Eli Lilly and Company (NYSE:LLY)July 30 at 6:13 AM | marketbeat.comEli Lilly (LLY) Poised for Upside After Recent Selloff, Says CitiJuly 30 at 6:13 AM | gurufocus.comDelap Wealth Advisory LLC Boosts Stock Position in Eli Lilly and Company (NYSE:LLY)July 30 at 6:13 AM | marketbeat.comFirst National Trust Co Lowers Holdings in Eli Lilly and Company (NYSE:LLY)July 30 at 6:13 AM | marketbeat.comTredje AP fonden Grows Holdings in Eli Lilly and Company (NYSE:LLY)July 30 at 6:13 AM | marketbeat.comEastern Bank Acquires 18,102 Shares of Eli Lilly and Company (NYSE:LLY)July 30 at 6:13 AM | marketbeat.comEli Lilly and Company (NYSE:LLY) Shares Sold by Vestcor IncJuly 30 at 6:13 AM | marketbeat.comFiera Capital Corp Purchases 3,522 Shares of Eli Lilly and Company (NYSE:LLY)July 30 at 6:13 AM | marketbeat.comNovo Nordisk Stock (NVO) Plunges 20% on Guidance Cut and CEO AppointmentJuly 29 at 10:00 PM | tipranks.comLilly set for strong quarter after Novo profit warningJuly 29 at 3:49 PM | reuters.comEli Lilly and Company (NYSE:LLY) Shares Down 4.2% - Here's What HappenedJuly 29 at 3:36 PM | marketbeat.comEli Lilly and Company (NYSE:LLY) Shares Gap Down - What's Next?July 29 at 12:51 PM | marketbeat.comEli Lilly Stock (LLY) Gets Dragged Down After Rival Novo Nordisk Lowers GuidanceJuly 29 at 12:40 PM | tipranks.comEli Lilly’s Jaypirca succeeds in late-stage trial against Imbruvica of J&J and AbbVieJuly 29 at 11:35 AM | msn.comEli Lilly and Company (NYSE:LLY) Shares Acquired by Harvest Fund Management Co. LtdJuly 29 at 7:25 AM | marketbeat.comEli Lilly and Company (NYSE:LLY) Shares Purchased by S&CO Inc.July 29 at 7:23 AM | marketbeat.comBanque Cantonale Vaudoise Takes $17.28 Million Position in Eli Lilly and Company (NYSE:LLY)July 29 at 7:14 AM | marketbeat.comLilly's cancer drug more effective than AbbVie's in head-to-head studyJuly 29 at 7:05 AM | reuters.comEli Lilly and Company (NYSE:LLY) Shares Acquired by Federated Hermes Inc.July 29 at 6:48 AM | marketbeat.comEli Lilly and Company (NYSE:LLY) Shares Bought by Geneos Wealth Management Inc.July 29 at 6:47 AM | marketbeat.comLilly's Jaypirca (pirtobrutinib), the first and only approved non-covalent (reversible) BTK inhibitor, met its primary endpoint in a head-to-head Phase 3 trial versus Imbruvica (ibrutinib) in CLL/SLLJuly 29 at 6:45 AM | prnewswire.comEli Lilly and Company (NYSE:LLY) is Cozad Asset Management Inc.'s 5th Largest PositionJuly 29 at 6:37 AM | marketbeat.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Eli Lilly & Co (LLY), Centene (CNC) and HCA Healthcare (HCA)July 29 at 6:34 AM | theglobeandmail.comEli Lilly and Company (LLY) Announces New Phase 3 Trial Results for OrforglipronJuly 29 at 6:34 AM | finance.yahoo.comN.E.W. Advisory Services LLC Raises Holdings in Eli Lilly and Company (NYSE:LLY)July 29 at 6:26 AM | marketbeat.comEli Lilly and Company (NYSE:LLY) Holdings Trimmed by Meeder Asset Management Inc.July 29 at 6:01 AM | marketbeat.comMeeder Advisory Services Inc. Raises Position in Eli Lilly and Company (NYSE:LLY)July 29 at 6:01 AM | marketbeat.comRamirez Asset Management Inc. Buys New Stake in Eli Lilly and Company (NYSE:LLY)July 29 at 5:41 AM | marketbeat.comEli Lilly and Company (NYSE:LLY) Holdings Cut by Indie Asset Partners LLCJuly 29 at 5:30 AM | marketbeat.comPicton Mahoney Asset Management Sells 42,480 Shares of Eli Lilly and Company (NYSE:LLY)July 29 at 5:19 AM | marketbeat.comMorgan Stanley Remains Bullish on Eli Lilly (LLY)July 28 at 8:31 PM | msn.comAnalyst Highlights ‘Game Changer’ Catalyst for Eli Lilly (LLY)July 28 at 5:16 PM | insidermonkey.comPromising Pharmaceutical Stocks To Keep An Eye On - July 28thJuly 28 at 4:03 PM | marketbeat.comEli Lilly Advances Clinical Study on TNG456 for Solid TumorsJuly 28 at 12:06 PM | tipranks.comPhysicians Financial Services Inc. Grows Stake in Eli Lilly and Company (NYSE:LLY)July 28 at 8:21 AM | marketbeat.comPatten & Patten Inc. TN Has $13.97 Million Stock Holdings in Eli Lilly and Company (NYSE:LLY)July 28 at 8:09 AM | marketbeat.comPTM Wealth Management LLC Acquires Shares of 474 Eli Lilly and Company (NYSE:LLY)July 28 at 7:36 AM | marketbeat.com Get Eli Lilly and Company News Delivered to You Automatically Sign up to receive the latest news and ratings for LLY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Videos LLY Media Mentions By Week LLY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LLY News Sentiment▼1.151.04▲Average Medical News Sentiment LLY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LLY Articles This Week▼16796▲LLY Articles Average Week Get Eli Lilly and Company News Delivered to You Automatically Sign up to receive the latest news and ratings for LLY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amgen News Today Biogen News Today Incyte News Today Moderna News Today Viking Therapeutics News Today Vertex Pharmaceuticals News Today AbbVie News Today Johnson & Johnson News Today Merck & Co., Inc. News Today Pfizer News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:LLY) was last updated on 7/30/2025 by MarketBeat.com Staff From Our PartnersAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and sea...Mode Mobile | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredNvidia’s next AI move could catch traders flat-footedTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredOne stock to replace Nvidia"I said 'SELL' before this stock dropped 90%. Today, I'm shouting 'BUY NOW' before it's too late." In 2000,...InvestorPlace | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredStrange Investment Secret Predicts Market's Next Move?A strange market signal discovered before the Great Depression has predicted nearly every major financial even...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eli Lilly and Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Eli Lilly and Company With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.